Empashield-S 25/100MG Tab — Uses, Dosage & Benefits

Empagliflozin 25 mg + Sitagliptin 100 mg tablet

Empagliflozin is an SGLT2 inhibitor that increases urinary glucose excretion by reducing glucose reabsorption in the kidneys. Sitagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing glucose-dependent insulin release and reducing glucagon secretion, thereby lowering blood glucose.

Oral tablet. Take exactly as prescribed by the doctor, usually once daily; may be taken with or without food. Maintain adequate hydration; follow diet and exercise advice. Do not stop without medical advice.

Always follow your doctor's prescription. Do not self-medicate.